19-19630255-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016573.4(GMIP):c.2621G>A(p.Arg874Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000023 in 1,566,288 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000092 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000016 ( 0 hom. )
Consequence
GMIP
NM_016573.4 missense
NM_016573.4 missense
Scores
3
6
10
Clinical Significance
Conservation
PhyloP100: 5.59
Genes affected
GMIP (HGNC:24852): (GEM interacting protein) This gene encodes a member of the ARHGAP family of Rho/Rac/Cdc42-like GTPase activating proteins. The encoded protein interacts with the Ras-related protein Gem through its N-terminal domain. Separately, it interacts with RhoA through a RhoGAP domain, and stimulates RhoA-dependent GTPase activity. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.15984061).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GMIP | NM_016573.4 | c.2621G>A | p.Arg874Gln | missense_variant | 21/21 | ENST00000203556.9 | NP_057657.2 | |
GMIP | NM_001288999.2 | c.2543G>A | p.Arg848Gln | missense_variant | 20/20 | NP_001275928.1 | ||
GMIP | NM_001288998.2 | c.2534G>A | p.Arg845Gln | missense_variant | 20/20 | NP_001275927.1 | ||
GMIP | XM_005259927.3 | c.2612G>A | p.Arg871Gln | missense_variant | 21/21 | XP_005259984.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GMIP | ENST00000203556.9 | c.2621G>A | p.Arg874Gln | missense_variant | 21/21 | 1 | NM_016573.4 | ENSP00000203556.3 | ||
GMIP | ENST00000587238.5 | c.2543G>A | p.Arg848Gln | missense_variant | 20/20 | 1 | ENSP00000467054.1 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152146Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
14
AN:
152146
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000377 AC: 8AN: 212098Hom.: 0 AF XY: 0.0000351 AC XY: 4AN XY: 114020
GnomAD3 exomes
AF:
AC:
8
AN:
212098
Hom.:
AF XY:
AC XY:
4
AN XY:
114020
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000156 AC: 22AN: 1414024Hom.: 0 Cov.: 33 AF XY: 0.0000158 AC XY: 11AN XY: 697916
GnomAD4 exome
AF:
AC:
22
AN:
1414024
Hom.:
Cov.:
33
AF XY:
AC XY:
11
AN XY:
697916
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000919 AC: 14AN: 152264Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74440
GnomAD4 genome
AF:
AC:
14
AN:
152264
Hom.:
Cov.:
32
AF XY:
AC XY:
10
AN XY:
74440
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
4
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 07, 2023 | The c.2621G>A (p.R874Q) alteration is located in exon 21 (coding exon 21) of the GMIP gene. This alteration results from a G to A substitution at nucleotide position 2621, causing the arginine (R) at amino acid position 874 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.
REVEL
Benign
Sift
Pathogenic
D;.
Sift4G
Pathogenic
D;D
Polyphen
D;.
Vest4
MutPred
Loss of solvent accessibility (P = 0.0023);.;
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at